Zobrazeno 1 - 10
of 83
pro vyhledávání: '"N. D. Selezneva"'
Autor:
I. K. Malashenkova, D. P. Ogurtsov, S. A. Krynskiy, N. A. Khailov, N. D. Selezneva, Ya. B. Fedorova, E. V. Ponomareva, I. V. Kolykhalov, S. I. Gavrilova, N. A. Didkovsky
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 805-812 (2021)
Alzheimer’s disease (AD) is currently the most common cause of dementia. A significant role in the pathogenesis of AD belongs to the activation of the mechanisms of neuroinflammation. There is a hypothesis that chronic infections may play a role in
Externí odkaz:
https://doaj.org/article/2506c94e7ca240439731c6d73451d236
Autor:
L. O. Minushkina, O. S. Chumakova, N. D. Selezneva, V. A. Evdokimova, V. S. Osmolovskata, K. A. Blagodatskikh, V. V. Nosikov, D. A. Zateyshchikov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 10, Pp 23-28 (2014)
Aim. To study the association of polymorphic markers of C-reactive protein genes (CRP), interleukine-6 (IL6), interleukine-10 (IL10), lymphotoxine alpha (LTA) and tumornecrosis factor alpha (TNFA) with LVH in patients with hypertensive disease (AH).M
Externí odkaz:
https://doaj.org/article/a316c88999a44053ae3d99f84da76c47
Publikováno v:
Psikhiatriya. 21:52-61
The aim of the study: evaluation of the impact of long-term effects of repeated courses of Actovegin therapy on indicators of minimal cognitive dysfunction (MCD) in relatives of patients with Alzheimer’s disease (AD).Study participant: 76 people wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::963404566545a63044d3c50a974af148
https://doi.org/10.30629/2618-6667-2023-21-1-52-61
https://doi.org/10.30629/2618-6667-2023-21-1-52-61
Autor:
B. B. Velichkovsky, D. V. Tatarinov, A. A. Khlebnikova, I. F. Roshchina, N. D. Selezneva, S. I. Gavrilova
Publikováno v:
Neuroscience and Behavioral Physiology. 51:1216-1221
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c40546051e2487433e2424d2398a2302
https://doi.org/10.1007/s11055-021-01182-3
https://doi.org/10.1007/s11055-021-01182-3
Autor:
B B, Velichkovsky, D V, Tatarinov, A A, Khlebnikova, A V, Ziberova, I F, Roshchina, N D, Selezneva, S I, Gavrilova
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 33(5)
Conflict adaptation effect in interference control tasks (like Stroop task or flanker task) consists in better interference suppression in incongruent trials following an incongruent trial. In a flanker task is shown that in normal cognitive aging th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f47c6e740e027b59470fc95cf3051032
https://pubmed.ncbi.nlm.nih.gov/33550759
https://pubmed.ncbi.nlm.nih.gov/33550759
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:30
To study the effects of a three-month course of therapy with citicoline, aimed at preventing the progression of cognitive deficit in 1st-degree relatives of patients with Alzheimer's disease (AD), depending on the carriage of theStudy participants: 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf22ec0847c11ebfaba3c8a4dcb881d
https://doi.org/10.17116/jnevro202112110230
https://doi.org/10.17116/jnevro202112110230
Autor:
N A Didkovsky, S A Krynskiy, Ya. B. Fedorova, I A Kompaneetz, I K Malashenkova, I. V. Kolyhalov, G. V. Kazanova, N A Hailov, S I Gavrilova, E. V. Ponomareva, N D Selezneva, D P Ogurtsov, M A Zharova
Publikováno v:
Russian Journal of Allergy. 13:90-91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f28af09fea5f87bb819d6f82f498b06f
https://doi.org/10.36691/rja412
https://doi.org/10.36691/rja412
Autor:
N. D. Selezneva, T. P. Serkova, T. V. Abramenko, I. V. Kolykhalov, N. N. Lermontova, Sergey O. Bachurin, G.A. Zharikov, Ya. B. Kalyn, S. I. Gavrilova, M. A. Myagkova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 136:49-52
We measured serum content of autoantibodies to β-amyloid protein Aβ1-42, its neurotoxic fragment Aβ25-35, vasopressin, bradykinin, thrombin, antithrombin III, α2-macroglobulin, and angiotensin II in patients with various forms of Alzheimer's deme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d660ff44b39c9ad9c5b37d8ff54e8f70
https://doi.org/10.1023/a:1026036829237
https://doi.org/10.1023/a:1026036829237
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 114(9)
Objective. To determine the therapeutic efficacy and safety of agomelatine (valdoxan) in elderly patients with mild and moderate depression during outpatient treatment. Material and methods. The 60-79-year-old age group consisted of 20 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6442c8ea8bd4f9785bdef1ed0e1223c
https://pubmed.ncbi.nlm.nih.gov/25403300
https://pubmed.ncbi.nlm.nih.gov/25403300